News and Insights

Patient and HCP preference for a new epinephrine nasal delivery device Written by: Erin Pohl Imagine the moment when a child has an allergic reaction and starts gasping for air because their throat is closing. The parent then has to find the life-saving medication and give it quickly and accurately to the child who may or may not be willing. This moment can happen anywhere and at anytime. The standard treatment for anaphylactic shock is epinephrine which is currently delivered via autoinjectors and syringes. To overcome known usability issues with epinephrine injectors like the EpiPen®️, Bryn Pharma, LLC is looking into a new route and device to deliver epinephrine-- the BiDose Epinephrine Nasal Spray. This new nasal spray device provides two intranasal sprays that are absorbed immediately through the mucous membranes in the nose to counteract anaphylaxis. Earlier this year, Core Human Factors teamed up with Bryn Pharma to investigate users’ preferences between the BiDose Epi

F e b r u a r y Happy Birthday Bill, Sarah, Irina and Becky! Bill at top of Willis Tower!   Sarah Camping! Irina Iceskating! Becky in Japan! What drew you to human factors and what drew you to Core? Bill: I became interested in Human Factors as it seemed like a practical implementation of engineering design. After finishing my PhD I knew I wanted out of academic research but wanted to continue doing intellectually stimulating research. Consulting seemed like a logical transition and it seemed like my background in research and technology would be relatable to the usability of medical devices. Core seemed to have great employees doing interesting research so I strongly pursued working here! Sarah: I've always been interested in health and human behavior, specifically related to chronic disease prevention and management. Core was a great fit because it combines research, behavior, and medicine into one career. Irina: I studied emotional memory and